Abstract CT246: A phase 2 multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN-145) cell therapy in patients with metastatic non-small cell lung cancer (mNSCLC) von Massarelli, Erminia, Goldberg, Zelanna, Cacovean, Alex, Yadav, Bhagyashree, Chen, Guang, Jagasia, Madan, Finckenstein, Friedrich Graf, Fardis, Maria, Sukari, Ammar

Volltext

Abstract CT244: A Phase 1/2 study evaluating the safety and efficacy of IOV-2001 in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lym... von Long, Meixiao, Woyach, Jennifer, Pinilla-Ibarz, Javier, Stephens, Deborah M., Cacovean, Alex, Fiaz, Rana, Goldberg, Zelanna, Jagasia, Madan, Finckenstein, Friedrich Graf, Fardis, Maria, Byrd, John C.

Volltext

Abstract CT235: A Phase 2, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumors von Gettinger, Scott, Kluger, Harriet, Schoenfeld, Adam, Betof-Warner, Allison, He, Kai, Sukari, Ammar, Doger de Speville Uribe, Bernard, Lee, Sylvia, Haefliger, Simon, Goldberg, Zelanna, Cacovean, Alex, Fiaz, Rana, Chen, Guang, Jagasia, Madan, Finckenstein, Friedrich Graf, Fardis, Maria, Jimeno, Antonio

Volltext

Safety and efficacy of lifileucel (LN-144), an autologous, tumor infiltrating lymphocyte cell therapy in combination with pembrolizumab for immune checkpoint inhibitor naïve patien... von Thomas, Sajeve Samuel, In, Gino Kim, Doger, Bernard, Haefliger, Simon, Martin-Liberal, Juan, Goldberg, Zelanna, Cacovean, Alex, Fiaz, Rana, Chen, Guang, Jagasia, Madan H., Graf Finckenstein, Friedrich, Fardis, Maria, Jimeno, Antonio

Volltext

P-269: COVALENT-101: a Phase 1 study of BMF-219, a novel oral covalent menin inhibitor, in patients with relapsed/refractory (R/R) acute leukemia, diffuse large B-cell lymphoma, an... von Ravandi, Farhad, Carraway, Hetty, Khouri, Jack, Kishtagari, Ashwin, Curran, Emily, Schiller, Gary, Yadav, Bhagyashree (Kelshikar), Morris, Steve, Cacovean, Alex, Mourya, Sanchita, Butler, Thomas, Lancet, Jeffrey

Volltext

A phase II study of autologous tumor infiltrating lymphocytes (TIL, LN-144/LN-145) in patients with solid tumors von Chesney, Jason Alan, Lutzky, Jose, Thomas, Sajeve Samuel, Nieva, Jorge J., Munoz Couselo, Eva, Martin-Liberal, Juan, Rodriguez-Moreno, Juan Francisco, Cacovean, Alex, Li, Huiling, Fardis, Maria, Gettinger, Scott N.

Volltext

POSTER: AML-522 COVALENT-101: Phase I Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/MLL1 Rearrangements, NPM1 Mutation), DLBCL, MM, and... von Ravandi, Farhad, Lancet, Jeffrey, Amor, Adrian Alegre, Badar, Talha, Barrientos, Jacqueline, Bashey, Asad, Burgues, Juan Miguel Bergua, Curran, Emily, Janssen, Jeroen, Jeyakumar, Deepa, Kishtagari, Ashwin, Montesinos, Pau, Morillo, Daniel, Rosenberg, Aaron, Schiller, Gary, Ahmed, Uzma, Cacovean, Alex, Morris, Steve, Follit, Courtney, Mandap, Clarissa, Butler, Thomas, Carraway, Hetty

Volltext

P-213 COVALENT-101: phase I study of BMF-219, a covalent menin inhibitor, in adult patients with AML, ALL (with KMT2A/ MLL1r, NPM1 mutations), DLBCL, MM, and CLL/SLL (NCT05153330) von Rosenberg, Aaron, Baljevic, Muhamed, Amor, Adrian Alegre, Barrientos, Jacqueline, Bashey, Asad, Baz, Rachid, Burgues, Juan Bergua, Delimpasi, Sosana, Kastritis, Efstathios, Latif, Tahir, Lee, Lisa, Mateos, Maria-Victoria, Morillo, Daniel, Montesinos, Pau, Parrondo, Ricardo, Schiller, Gary, Curran, Emily, Kishtagari, Ashwin, Butler, Thomas, Cacovean, Alex, Follit, Courtney, Mandap, Clarissa, Morris, Steve, Khouri, Jack

Volltext

AML-522 COVALENT-101: Phase I Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/MLL1 Rearrangements, NPM1 Mutation), DLBCL, MM, and CLL/SLL... von Ravandi, Farhad, Lancet, Jeffrey, Amor, Adrian Alegre, Badar, Talha, Barrientos, Jacqueline, Bashey, Asad, Burgues, Juan Miguel Bergua, Curran, Emily, Janssen, Jeroen, Jeyakumar, Deepa, Kishtagari, Ashwin, Montesinos, Pau, Morillo, Daniel, Rosenberg, Aaron, Schiller, Gary, Ahmed, Uzma, Cacovean, Alex, Morris, Steve, Follit, Courtney, Mandap, Clarissa, Butler, Thomas, Carraway, Hetty

Volltext

Abstract A003: COVALENT-102: A phase 1/1b dose finding study of BMF-219, an oral covalent menin inhibitor, in patients with metastatic non-small cell lung cancer (NSCLC), pancreati... von Cohen, Stacey A., Fountzilas, Christos, Sommerhalder, David, Patel, Sandip, Benson, Ai, He, Kai, Ganti, Apar, Spira, Alex, Yadav, Bhagyashree (Kelshikar), Cacovean, Alex, Morris, Steve, Butler, Tom, Hong, David

Volltext

Abstract CT210: A phase 1 study of BMF-219, a novel oral irreversible menin inhibitor, as single-agent in patients with relapsed/refractory (R/R) acute leukemia (AL), diffuse large... von Ravandi-Kashani, Farhad, Kishtagari, Ashwin, Carraway, Hetty, Curran, Emily, Schiller, Gary, Cacovean, Alex, Yadav, Bhagyashree, Butler, Thomas, Lancet, Jeffrey

Volltext

A phase 1b/2 study of ibrutinib combination therapy in selected advanced genitourinary and gastrointestinal tumors von Berlin, Jordan, Posadas, Edwin M., Macarulla, Teresa Mercade, Cacovean, Alex, Eckert, Karl, Munneke, Brian, Cole, George W., James, Danelle Frances, Motzer, Robert J.

Volltext